R&D Meets The Crowdscape: BioMed X Looks Outside For Insight

An extended inter-disciplinary approach to preclinical research may offer the best leads against today’s biggest challenges in medicine.

 
• By William Looney
  
Crowdsource
Crowd science appeals as a remedy for declining productivity in the biopharma pipeline • Source: Gayle Rembold Furbert
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from In Vivo